Detalles de la búsqueda
1.
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.
Neuro Oncol
; 24(11): 1935-1949, 2022 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35511454
2.
Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network.
Eur J Cancer
; 135: 89-97, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32554315
3.
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer.
Eur J Cancer
; 108: 120-128, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30654297
4.
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer.
Eur J Cancer
; 100: 27-34, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29936064
Resultados
1 -
4
de 4
1
Próxima >
>>